Implanet Granted CE Mark Renewal for Madison Knee
European authorities extended the CE Mark approvals on the entire range of MADISON knee devices for a further four years....
Jun 09, 2020,
Joint Replacement
ORTHOFLASH 
Rejoint YourKnee Gains Additional CE Mark Approval
Rejoint offers more than 6,300 femoral variations including multiple designs and coatings. FDA 510(k) clearance is expected in 2Q21....
Jun 08, 2020,
Episurf Medical to Gain Additional European Patent
The patent is titled “System and method for creating a decision support material indicating damage to an anatomical joint.”...
Jun 08, 2020,
Study Results: Smith+Nephew’s OXINIUM on XLPE for Total Hips
Study results indicate that procedures using OXINIUM on XLPE had the lowest risk of revision of all bearing combinations for...
Jun 03, 2020,
Medacta Gains CE Mark for Shoulder Implants
The two components allow surgeons to widen clinical use of the system by addressing more patient morphologies and pathologies....
Jun 03, 2020,
Conformis Settles Patent Dispute with Zimmer Biomet
Conformis and Zimmer Biomet settled disputes related to patient-specific instrument patents for use with off-the-shelf knee, hip and shoulder implants....
May 28, 2020,
First Korean Patent Approval for Episurf Medical
The patent covers Episurf Medical’s 3D-based damage marking technology, central to the Episealer® implant system....
May 28, 2020,
Smith+Nephew Launches New JOURNEY II Unicompartmental Knee
The new system debuts a lateral-specific tibia baseplate and an increased size range for femoral components and medial tibia baseplates....
May 20, 2020,
Medacta Expands its Hip and Shoulder Portfolio
Medacta gained FDA clearance for its M-Vizion Femoral Revision System and its Long Humeral Diaphysis for shoulder joint replacement....
May 13, 2020,
DJO’s Outpatient Risk Algorithm 6-Month Trial Available
The risk stratification tool intends to help surgeons transition more total joint arthroplasty cases to outpatient or same-day discharge....
May 12, 2020,
Loading new posts...
No more posts
